Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6-month interim report of a 3-year study
about
Transdermal rotigotine: a clinically innovative dopamine-receptor agonist for the management of Parkinson's diseasePramipexole-induced somnolence and episodes of daytime sleep.Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease.Ropinirole and pramipexole, the new agonists.Treatment of Parkinson's disease should begin with a dopamine agonist.Pharmacological treatment of Parkinson's disease.Neurotoxicity of MPTP.Long term outcome of unilateral pallidotomy: follow up of 15 patients for 3 years.Ropinirole in the treatment of Parkinson's disease.Study in Parkinson disease of exercise (SPARX): translating high-intensity exercise from animals to humansUpdate on ropinirole in the treatment of Parkinson's disease.Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.Comparison of the functional potencies of ropinirole and other dopamine receptor agonists at human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells.Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease.Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naïve MPTP-lesioned common marmosets (Callithrix jacchus).Dosing with ropinirole in a clinical setting.Zolpidem in a minimally conscious state.Progressive catatonia.Reassessment of unilateral pallidotomy in Parkinson's disease. A 2-year follow-up study.Early (Uncomplicated) Parkinson's Disease
P2860
Q28266116-64FB58CD-591B-4FD4-8A00-42AFD9706E3FQ31422765-4504BBA8-46D4-44D7-AFD4-22E906011A98Q33260250-8472DED3-975C-4BD3-90BB-07675B830182Q33714127-65C10B79-C33D-4A68-B2E9-2A8081834AF3Q33737392-1E432294-A9C8-4101-9175-ACAD720C5C12Q34048261-BEC27AF1-0136-4EDE-A30B-5096A468643BQ34523844-945EA2B8-9640-4299-A469-9A6067E87BE1Q35459081-4B2C9B3F-85D8-4318-AFEE-C699CA7FC8CBQ36181342-5020418E-4000-464C-A57B-37C4E3E6F885Q37161380-CA23241C-08DB-4A33-AB13-A5253EDF78F2Q37531960-11DB4436-DF2E-40C8-8328-685A74ABC1BBQ38070888-A855B1DE-6D09-4897-8322-3122D7450DD6Q43194163-7DE01959-401E-408F-B278-E582CE89AF55Q43461514-5910F1A3-0E74-4045-BB1D-1A452C603642Q43693344-8DBA6A04-5107-4B15-9132-058A77D6641EQ44133261-8951F858-10E9-47A9-9CB7-650EB1949E34Q46816718-3C2355E8-27DA-4E79-92BB-D919B7522F40Q48236428-A1417379-312E-49B4-A090-4567CF73327BQ48254172-A3BA9233-9171-4A55-8CB9-0A44E0E4A393Q58870319-AD5CCA9D-2B8E-43C8-B438-886018C0C878
P2860
Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6-month interim report of a 3-year study
description
im Januar 1998 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 January 1998
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 1998
@uk
name
Ropinirole versus bromocriptin ...... terim report of a 3-year study
@en
Ropinirole versus bromocriptin ...... terim report of a 3-year study
@nl
type
label
Ropinirole versus bromocriptin ...... terim report of a 3-year study
@en
Ropinirole versus bromocriptin ...... terim report of a 3-year study
@nl
prefLabel
Ropinirole versus bromocriptin ...... terim report of a 3-year study
@en
Ropinirole versus bromocriptin ...... terim report of a 3-year study
@nl
P2093
P2860
P50
P356
P1433
P1476
Ropinirole versus bromocriptin ...... 3-year study. 053 Study Group
@en
P2093
P2860
P356
10.1002/MDS.870130112
P407
P577
1998-01-01T00:00:00Z